BRPI0606528A2 - composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma - Google Patents
composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesmaInfo
- Publication number
- BRPI0606528A2 BRPI0606528A2 BRPI0606528-7A BRPI0606528A BRPI0606528A2 BR PI0606528 A2 BRPI0606528 A2 BR PI0606528A2 BR PI0606528 A BRPI0606528 A BR PI0606528A BR PI0606528 A2 BRPI0606528 A2 BR PI0606528A2
- Authority
- BR
- Brazil
- Prior art keywords
- male infertility
- manufacture
- composition
- treatment medicines
- infertility treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composição Para Uso no Fabrico de Medicamentos de Tratamento da Infertilidade Masculina e Uso da Mesma. Perfis Normais de Testosterona Total de Secreção no Soro em Jovens e Idosos Saudáveis Composições que compreendem trans-clomifeno podem ser usadas para tratamento da infertilidade masculina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65001805P | 2005-02-04 | 2005-02-04 | |
PCT/US2006/003882 WO2006084153A2 (en) | 2005-02-04 | 2006-02-03 | Methods and materials with trans-clomiphene for the treatment of male infertility |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0606528A2 true BRPI0606528A2 (pt) | 2009-06-30 |
BRPI0606528A8 BRPI0606528A8 (pt) | 2018-03-13 |
Family
ID=36777974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0606528A BRPI0606528A8 (pt) | 2005-02-04 | 2006-02-03 | composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma |
Country Status (14)
Country | Link |
---|---|
US (1) | US20090215906A1 (pt) |
EP (1) | EP1848416A4 (pt) |
JP (1) | JP2008530016A (pt) |
KR (1) | KR20070100811A (pt) |
CN (1) | CN101115477A (pt) |
AU (1) | AU2006210481B2 (pt) |
BR (1) | BRPI0606528A8 (pt) |
CA (1) | CA2595363C (pt) |
MX (1) | MX2007009077A (pt) |
NZ (1) | NZ556499A (pt) |
PL (1) | PL219509B1 (pt) |
RU (1) | RU2404757C2 (pt) |
WO (1) | WO2006084153A2 (pt) |
ZA (1) | ZA200705906B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE406153T1 (de) | 2001-07-09 | 2008-09-15 | Repros Therapeutics Inc | Verfahren und materialien für die behandlung des testosteron-mangels bei männern |
US7737185B2 (en) | 2001-07-09 | 2010-06-15 | Repros Therapeutics Inc. | Methods and compositions with trans-clomiphene |
RU2413508C2 (ru) | 2005-03-22 | 2011-03-10 | Репрос Терапьютикс Инк. | Режимы дозирования транс-кломифена |
NZ591955A (en) * | 2007-10-16 | 2011-10-28 | Repros Therapeutics Inc | Trans-clomiphene for diabetes mellitus type 2 |
IT1395957B1 (it) | 2009-05-19 | 2012-11-02 | Pharmaguida S R L | Uso di una combinazione di d-aspartato e l-aspartato per il trattamento della infertilita' maschile. |
UA113291C2 (xx) | 2011-08-04 | 2017-01-10 | Метаболіти транскломіфену і їх застосування | |
US20140235601A1 (en) * | 2011-08-09 | 2014-08-21 | Kenneth W. Adams | Use of Aromatase Inhibitor Or Estrogen Blocker For Increasing Spermatogenesis Or Testosterone Levels In Males |
RU2480256C1 (ru) * | 2012-04-04 | 2013-04-27 | Федеральное государственное бюджетное учреждение "Научный центр проблем здоровья семьи и репродукции человека" Сибирского отделения Российской академии медицинских наук | Способ комплексного лечения нормогонадотропного бесплодия у мужчин |
CN104994877A (zh) | 2012-11-02 | 2015-10-21 | 利普生物药剂公司 | 用于癌症治疗的反式-克罗米芬 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4061733A (en) * | 1976-10-15 | 1977-12-06 | Narayan Vishwanath Gunjikar | Veterinary compositions for inducing estrus in animals and method |
US4729999A (en) * | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
US4820736A (en) * | 1987-03-20 | 1989-04-11 | Yale University | Use of clomiphene to predict fertility in a human female |
JPH04312522A (ja) | 1991-04-08 | 1992-11-04 | Yoshiaki Kawashima | 徐放性錠剤の製造方法 |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5681585A (en) | 1991-12-24 | 1997-10-28 | Euro-Celtique, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5776923A (en) * | 1993-01-19 | 1998-07-07 | Endorecherche, Inc. | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
WO1995035093A1 (en) | 1994-06-17 | 1995-12-28 | University Of Nebraska Board Of Regents | In situ gel-forming delivery vehicle for bio-affecting substances, and method of use |
DE4435368A1 (de) * | 1994-09-22 | 1996-03-28 | Schering Ag | Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann |
US6221399B1 (en) * | 1995-08-17 | 2001-04-24 | Csir | Method of making controlled release particles of complexed polymers |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
IL120262A (en) * | 1996-02-28 | 2001-01-28 | Pfizer | Droloxifene and derivatives thereof for use in increasing serum testosterone levels |
EP0935523B1 (en) | 1996-10-28 | 2004-09-29 | Inc. General Mills | Embedding and encapsulation of controlled release particles |
BR9809064A (pt) * | 1997-04-03 | 2002-01-02 | Guilford Pharm Inc | Polìmeros biodegradáveis de poliéster de tereftalato-polifosfato, composições, artigos e métodos para fazer e usar os mesmos |
US6653297B1 (en) * | 1997-07-03 | 2003-11-25 | Medical College Of Hampton Roads | Control of selective estrogen receptor modulators |
US6342250B1 (en) * | 1997-09-25 | 2002-01-29 | Gel-Del Technologies, Inc. | Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
WO2000007996A2 (en) * | 1998-08-07 | 2000-02-17 | Chiron Corporation | Pyrazoles as estrogen receptor modulators |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6583129B1 (en) * | 1999-06-11 | 2003-06-24 | Watson Pharmaceuticals, Inc. | Administration of non-oral androgenic steroids to women |
CA2321321A1 (en) * | 1999-09-30 | 2001-03-30 | Isotis B.V. | Polymers loaded with bioactive agents |
AU3104301A (en) * | 2000-01-20 | 2001-07-31 | Noven Pharmaceuticals, Inc. | Compositions and methods to effect the release profile in the transdermal administration of active agents |
US6391920B1 (en) * | 2000-05-26 | 2002-05-21 | Harry Fisch | Methods of treating androgen deficiency in men using selective antiestrogens |
US7067557B2 (en) * | 2000-05-26 | 2006-06-27 | Harry Fisch | Methods of treating androgen deficiency in men using selective antiestrogens |
US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
WO2002055020A2 (en) * | 2000-12-11 | 2002-07-18 | Testocreme Llc | Topical testosterone formulations and associated methods |
US7173064B2 (en) * | 2001-07-09 | 2007-02-06 | Repros Therapeutics Inc. | Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy |
ATE406153T1 (de) * | 2001-07-09 | 2008-09-15 | Repros Therapeutics Inc | Verfahren und materialien für die behandlung des testosteron-mangels bei männern |
US6645974B2 (en) * | 2001-07-31 | 2003-11-11 | Merck & Co., Inc. | Androgen receptor modulators and methods for use thereof |
US20060269611A1 (en) * | 2001-11-29 | 2006-11-30 | Steiner Mitchell S | Prevention and treatment of androgen-deprivation induced osteoporosis |
US7105679B2 (en) * | 2001-12-19 | 2006-09-12 | Kanojia Ramesh M | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
-
2006
- 2006-02-03 NZ NZ556499A patent/NZ556499A/en not_active IP Right Cessation
- 2006-02-03 AU AU2006210481A patent/AU2006210481B2/en not_active Ceased
- 2006-02-03 KR KR1020077019148A patent/KR20070100811A/ko not_active Application Discontinuation
- 2006-02-03 JP JP2007554250A patent/JP2008530016A/ja active Pending
- 2006-02-03 BR BRPI0606528A patent/BRPI0606528A8/pt not_active IP Right Cessation
- 2006-02-03 CA CA2595363A patent/CA2595363C/en not_active Expired - Fee Related
- 2006-02-03 CN CNA2006800041575A patent/CN101115477A/zh active Pending
- 2006-02-03 PL PL383722A patent/PL219509B1/pl unknown
- 2006-02-03 EP EP06720243A patent/EP1848416A4/en not_active Withdrawn
- 2006-02-03 WO PCT/US2006/003882 patent/WO2006084153A2/en active Application Filing
- 2006-02-03 MX MX2007009077A patent/MX2007009077A/es active IP Right Grant
- 2006-02-03 US US11/814,068 patent/US20090215906A1/en not_active Abandoned
- 2006-02-03 RU RU2007132971/15A patent/RU2404757C2/ru not_active IP Right Cessation
-
2007
- 2007-07-18 ZA ZA200705906A patent/ZA200705906B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1848416A4 (en) | 2008-09-24 |
EP1848416A2 (en) | 2007-10-31 |
AU2006210481B2 (en) | 2011-12-08 |
WO2006084153A2 (en) | 2006-08-10 |
CA2595363C (en) | 2012-03-27 |
MX2007009077A (es) | 2007-09-13 |
AU2006210481A1 (en) | 2006-08-10 |
PL383722A1 (pl) | 2008-05-12 |
NZ556499A (en) | 2011-02-25 |
ZA200705906B (en) | 2008-04-30 |
RU2404757C2 (ru) | 2010-11-27 |
RU2007132971A (ru) | 2009-03-10 |
CN101115477A (zh) | 2008-01-30 |
JP2008530016A (ja) | 2008-08-07 |
KR20070100811A (ko) | 2007-10-11 |
WO2006084153A3 (en) | 2006-11-02 |
CA2595363A1 (en) | 2006-08-10 |
BRPI0606528A8 (pt) | 2018-03-13 |
US20090215906A1 (en) | 2009-08-27 |
PL219509B1 (pl) | 2015-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0606528A2 (pt) | composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma | |
BRPI0717845A2 (pt) | Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos | |
NO20065368L (no) | Terapeutiske blandinger inneholdende minst et pyrrolobenzodiazepinderivat og fludarabin | |
DOP2013000105A (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis | |
DK2321321T3 (da) | Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister | |
DOP2010000304A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
CR10566A (es) | Compuestos heterociclicos adecuados para el tratamiento de enfermedades relacionadas con nivel elevado de lipidos | |
CR10838A (es) | Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis | |
CR9949A (es) | Inhibidores de proteina activadora de la 5-lipoxigenasa (flap) | |
UY28931A1 (es) | Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis | |
AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
NO20074431L (no) | Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer | |
BRPI0410503A (pt) | uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição | |
BRPI0612309B8 (pt) | compostos e composições farmacêuticas antivirais | |
NO20074446L (no) | DR5-antistoffer og anvendelser derav | |
ECSP056210A (es) | Preparación y uso de derivados de alquilarilo para el tratamiento de la obesidad | |
CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
ECSP088763A (es) | Nuevas combinaciones terapéuticas para el tratamiento de la depresión | |
EA200701820A1 (ru) | Применение диосметиновых соединений при лечении и профилактике тромботических патологий | |
AR034900A1 (es) | Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica | |
NO20092073L (no) | Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav | |
BRPI0512503A (pt) | composição que compreende ácido lático e lactoferrina | |
CY1111762T1 (el) | Διενυδρη παμοϊκη ολανζαπiνη | |
RS54140B1 (en) | USE OF 24-ORDER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 14A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2551 DE 26-11-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |